Sotac Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹77 crore and net profit of ₹5.00 crore for the September 2026 quarter.
Sotac Pharma. (NSE: SOTAC-SM) closed at ₹135.00 on 20 Nov 2026, up 8.0% over the past year. Its market capitalisation is ₹149 crore and it trades at 17.2 times earnings.
Incorporated in 2015, Sotac Pharmaceuticals Ltd manufactures and sells a wide range of pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.